252 related articles for article (PubMed ID: 21402791)
1. Control of bone formation by the serpentine receptor Frizzled-9.
Albers J; Schulze J; Beil FT; Gebauer M; Baranowsky A; Keller J; Marshall RP; Wintges K; Friedrich FW; Priemel M; Schilling AF; Rueger JM; Cornils K; Fehse B; Streichert T; Sauter G; Jakob F; Insogna KL; Pober B; Knobeloch KP; Francke U; Amling M; Schinke T
J Cell Biol; 2011 Mar; 192(6):1057-72. PubMed ID: 21402791
[TBL] [Abstract][Full Text] [Related]
2. The Wnt serpentine receptor Frizzled-9 regulates new bone formation in fracture healing.
Heilmann A; Schinke T; Bindl R; Wehner T; Rapp A; Haffner-Luntzer M; Nemitz C; Liedert A; Amling M; Ignatius A
PLoS One; 2013; 8(12):e84232. PubMed ID: 24391920
[TBL] [Abstract][Full Text] [Related]
3. Frizzled-4 is required for normal bone acquisition despite compensation by Frizzled-8.
Kushwaha P; Kim S; Foxa GE; Michalski MN; Williams BO; Tomlinson RE; Riddle RC
J Cell Physiol; 2020 Oct; 235(10):6673-6683. PubMed ID: 31985040
[TBL] [Abstract][Full Text] [Related]
4. N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation.
Haÿ E; Laplantine E; Geoffroy V; Frain M; Kohler T; Müller R; Marie PJ
Mol Cell Biol; 2009 Feb; 29(4):953-64. PubMed ID: 19075000
[TBL] [Abstract][Full Text] [Related]
5. Wnt signaling control of bone cell apoptosis.
Bodine PV
Cell Res; 2008 Feb; 18(2):248-53. PubMed ID: 18212734
[TBL] [Abstract][Full Text] [Related]
6. Osteoblast-targeted expression of Sfrp4 in mice results in low bone mass.
Nakanishi R; Akiyama H; Kimura H; Otsuki B; Shimizu M; Tsuboyama T; Nakamura T
J Bone Miner Res; 2008 Feb; 23(2):271-7. PubMed ID: 17907918
[TBL] [Abstract][Full Text] [Related]
7. Msx2 exerts bone anabolism via canonical Wnt signaling.
Cheng SL; Shao JS; Cai J; Sierra OL; Towler DA
J Biol Chem; 2008 Jul; 283(29):20505-22. PubMed ID: 18487199
[TBL] [Abstract][Full Text] [Related]
8. Roles of Wnt signals in bone resorption during physiological and pathological states.
Maeda K; Takahashi N; Kobayashi Y
J Mol Med (Berl); 2013 Jan; 91(1):15-23. PubMed ID: 23111637
[TBL] [Abstract][Full Text] [Related]
9. The role of the Wnt signaling pathway in osteoblast commitment and differentiation.
Yavropoulou MP; Yovos JG
Hormones (Athens); 2007; 6(4):279-94. PubMed ID: 18055419
[TBL] [Abstract][Full Text] [Related]
10. Wnt signaling and cellular metabolism in osteoblasts.
Karner CM; Long F
Cell Mol Life Sci; 2017 May; 74(9):1649-1657. PubMed ID: 27888287
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 2 stimulation of osteoblast differentiation and bone formation is mediated by modulation of the Wnt signaling pathway.
Fei Y; Xiao L; Doetschman T; Coffin DJ; Hurley MM
J Biol Chem; 2011 Nov; 286(47):40575-83. PubMed ID: 21987573
[TBL] [Abstract][Full Text] [Related]
12. Wnt-5a/Frizzled9 Receptor Signaling through the Gαo-Gβγ Complex Regulates Dendritic Spine Formation.
Ramírez VT; Ramos-Fernández E; Henríquez JP; Lorenzo A; Inestrosa NC
J Biol Chem; 2016 Sep; 291(36):19092-107. PubMed ID: 27402827
[TBL] [Abstract][Full Text] [Related]
13. Gsα enhances commitment of mesenchymal progenitors to the osteoblast lineage but restrains osteoblast differentiation in mice.
Wu JY; Aarnisalo P; Bastepe M; Sinha P; Fulzele K; Selig MK; Chen M; Poulton IJ; Purton LE; Sims NA; Weinstein LS; Kronenberg HM
J Clin Invest; 2011 Sep; 121(9):3492-504. PubMed ID: 21804192
[TBL] [Abstract][Full Text] [Related]
14. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.
Li J; Sarosi I; Cattley RC; Pretorius J; Asuncion F; Grisanti M; Morony S; Adamu S; Geng Z; Qiu W; Kostenuik P; Lacey DL; Simonet WS; Bolon B; Qian X; Shalhoub V; Ominsky MS; Zhu Ke H; Li X; Richards WG
Bone; 2006 Oct; 39(4):754-66. PubMed ID: 16730481
[TBL] [Abstract][Full Text] [Related]
15. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N
Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
[TBL] [Abstract][Full Text] [Related]
16. Wnt signaling acts and is regulated in a human osteoblast differentiation dependent manner.
Eijken M; Meijer IM; Westbroek I; Koedam M; Chiba H; Uitterlinden AG; Pols HA; van Leeuwen JP
J Cell Biochem; 2008 May; 104(2):568-79. PubMed ID: 18186078
[TBL] [Abstract][Full Text] [Related]
17. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice.
Bodine PV; Zhao W; Kharode YP; Bex FJ; Lambert AJ; Goad MB; Gaur T; Stein GS; Lian JB; Komm BS
Mol Endocrinol; 2004 May; 18(5):1222-37. PubMed ID: 14976225
[TBL] [Abstract][Full Text] [Related]
18. Frizzled 9 knock-out mice have abnormal B-cell development.
Ranheim EA; Kwan HC; Reya T; Wang YK; Weissman IL; Francke U
Blood; 2005 Mar; 105(6):2487-94. PubMed ID: 15572594
[TBL] [Abstract][Full Text] [Related]
19. Neuromedin U (NMU) regulates osteoblast differentiation and activity.
Hsiao YT; Jestes KJ; Jackson KL; Zukosky T; Squire ME; Hum JM; Lowery JW
Biochem Biophys Res Commun; 2020 Apr; 524(4):890-894. PubMed ID: 32057362
[TBL] [Abstract][Full Text] [Related]
20. Wnt signaling and osteoblastogenesis.
Bodine PV; Komm BS
Rev Endocr Metab Disord; 2006 Jun; 7(1-2):33-9. PubMed ID: 16960757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
